Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P504: Stability observations in tacrolimus suppositoriesECCO '16 Amsterdam
Year: 2016
Authors:

M. Lie*1, E. Jansen2, P. Hoeben2, R. Zaal3, D. Hodes2, M. Rosman2, W. Loos2, J. van der Woude1

1Erasmus MC, Gastroenterology and Hepatology, Rotterdam, Netherlands, 2TioFarma BV, Oud-Beijerland, Netherlands, 3Erasmus Medical Centre, Hospital Pharmacy, Rotterdam, Netherlands

P505: The effect of using a question prompt list in outpatient clinic consultations in a Dutch inflammatory bowel disease populationECCO '16 Amsterdam
Year: 2016
Authors:

N. Peek-Kuijt*1, M. de Jong1, N. Srivastava2, R. Veenendaal1, P. Maljaars1, L. van Bodegom-Vos3, A. Linn4, A. van der Meulen-de Jong1

1Leiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, Netherlands, 2Medical Centre Haaglanden, Department of Gastroenterology and Hepatology, The Hague, Netherlands, 3Leiden University Medical Centre, Department of Medical Decision Making, Leiden, Netherlands, 4University of Amsterdam, Amsterdam School of Communication Research (ASCoR), Amsterdam, Netherlands

P506: Serum infliximab and antibodies to infliximab levels in Crohn’s disease and ulcerative colitis patients on long-term maintenance therapyECCO '16 Amsterdam
Year: 2016
Authors:

M. Waterman*1, H. Bar Yoseph1, B. Ungar2, S. Ben - Horin2, Y. Chowers1

1Rambam Health Care Campus, Department of Gastroenterology, Haifa, Israel, 2Sheba Medical Centre, Department of Gastroenterology, Ramat Gan, Israel

P507: Clinical role, optimal timing and frequency of measurement of serum infliximab levels and anti-infliximab antibody titres in patients with inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

R. Bor*1, K. Farkas1, A. Bálint1, A. Milassin1, M. Rutka1, M. Matuz2, F. Nagy1, A. Fábián1, Z. Szepes1, T. Molnar1

1University of Szeged, First Department of Medicine, Szeged, Hungary, 2University of Szeged, Faculty of Pharmacy, Szeged, Hungary

P508: Pregnancy outcomes in patients with inflammatory bowel disease experiencing flare ups during foetal developmentECCO '16 Amsterdam
Year: 2016
Authors:

Y. Yokoyama*1, H. Tanaka2, T. Miyazaki1, T. Sato1, M. Kawai1, Y. Kita1, K. Kamikozuru1, M. Iimuro1, N. Hida1, S. Nakamura1

1Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine, Nishinomiya, Japan, 2Hyogo College of Medicine, Department of Obstetrics and Gynaecology, Nishinomiya, Japan

P509: What is the effect of inflammatory bowel disease on sedation rates at colonoscopy?ECCO '16 Amsterdam
Year: 2016
Authors:

M. Walshe*, C. Moran, G. Horgan, G. Cullen, H. Mulcahy, G. Doherty

St Vincent’s University Hospital, Department of Gastroenterology and Centre for Colorectal Disease, Dublin, Ireland

P510: Skin anergy and latent tuberculosis in inflammatory bowel disease patientsECCO '16 Amsterdam
Year: 2016
Authors:

C. Herrera de Guise*, V. Robles, N. Borruel, E. Navarro, F. Casellas

Unitat d’Atenció Crohn-Colitis. Hospital Universitari Vall d’Hebron, Digestive Diseases Research, Barcelona, Spain

P511: Utilisation and efficacy of oral iron therapy in patients with iron deficiency anaemia in a nationwide cohort of ulcerative colitis patientsECCO '16 Amsterdam
Year: 2016
Authors:

D. Patel*1, N. Khan2

1Mercy Catholic Medical Centre, Internal Medicine, Philadelphia, Pennsylvania, United States, 2University of Pennsylvania, Internal Medicine, Philadelphia, Pennsylvania, United States